New Jersey Patent of the Month – May 2024
ElectroCore, Inc., a leading bioelectronic medicine company, has made significant strides in the field of medical innovation with its latest invention aimed at treating symptoms of central nervous system disorders. This groundbreaking method utilizes non-invasive vagus nerve stimulation to provide relief to patients suffering from conditions such as fibromyalgia, anxiety disorders, post-traumatic stress disorder (PTSD), and traumatic brain injury.
The method involves positioning a contact surface of a device on the anterior portion of the neck, applying electrical impulses transcutaneously to the vagus nerve according to a specific stimulation protocol. These impulses, administered multiple times a day over several days, effectively modify the vagus nerve to alleviate symptoms associated with the respective central nervous system disorder.
What makes this invention truly revolutionary is its non-invasive nature and precise stimulation protocol. Unlike traditional methods that may involve invasive procedures or medications with potential side effects, this approach offers a safer and more targeted solution. By harnessing the body’s natural pathways and utilizing advanced technology, ElectroCore has developed a method that not only addresses the symptoms but also promotes overall well-being.
The device itself comprises one or more electrodes coupled to an energy source, providing a user-friendly interface for patients. With electrodes attached to the neck, the device delivers electrical impulses with specific parameters tailored to each individual’s needs. The stimulation protocol, including the frequency and duration of impulses, ensures optimal efficacy while minimizing discomfort.
Moreover, this method holds promise for a wide range of central nervous system disorders, offering a versatile treatment option for patients with varying needs. Whether it’s managing chronic pain associated with fibromyalgia or alleviating the symptoms of anxiety and PTSD, this innovation opens new possibilities for improving quality of life.
The potential impact of this invention extends beyond symptom management. By targeting the underlying mechanisms of central nervous system disorders, such as the release of inhibitory neurotransmitters in the brain, ElectroCore’s method represents a significant advancement in the field of neurostimulation.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.
Are you eligible?
Why choose us?
Pass an Audit?
What is the R&D Tax Credit?
The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.
Never miss a deadline again
Stay up to date on IRS processes
Discover R&D in your industry
R&D Tax Credit Preparation Services
Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.
If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.
R&D Tax Credit Audit Advisory Services
creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.
Our Fees
Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/
Choose your state
